Iridian Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.33M | Sell |
21,625
-3,449
| -14% | -$1.13M | 2.57% | 12 |
|
|
2025
Q4 | $8.79M | Sell |
25,074
-27,029
| -52% | -$9.13M | 3.24% | 11 |
|
|
2025
Q3 | $16.8M | Buy |
52,103
+5,481
| +12% | +$1.7M | 6.63% | 4 |
|
|
2025
Q2 | $18.1M | Sell |
46,622
-5,369
| -10% | -$2.16M | 6.28% | 5 |
|
|
2025
Q1 | $22.6M | Sell |
51,991
-8,206
| -14% | -$3.29M | 7.09% | 3 |
|
|
2024
Q4 | $22.2M | Buy |
60,197
+21,043
| +54% | +$8.81M | 5.91% | 5 |
|
|
2024
Q3 | $20.4M | Buy |
39,154
+3,786
| +11% | +$2.02M | 4.36% | 6 |
|
|
2024
Q2 | $19.2M | Sell |
35,368
-4,342
| -11% | -$2.3M | 4.32% | 7 |
|
|
2024
Q1 | $20.6M | Sell |
39,710
-4,706
| -11% | -$2.34M | 4.04% | 8 |
|
|
2023
Q4 | $20.9M | Sell |
44,416
-10,271
| -19% | -$4.75M | 3.8% | 8 |
|
|
2023
Q3 | $23.8M | Sell |
54,687
-45,219
| -45% | -$20.5M | 4.82% | 5 |
|
|
2023
Q2 | $44.4M | Buy |
99,906
+7,329
| +8% | +$3.38M | 4.13% | 5 |
|
|
2023
Q1 | $42.6M | Buy |
92,577
+31,225
| +51% | +$14.9M | 3.49% | 9 |
|
|
2022
Q4 | $31.5M | Sell |
61,352
-4,329
| -7% | -$2.2M | 3.03% | 12 |
|
|
2022
Q3 | $29.8M | Buy |
65,681
+2,810
| +4% | +$1.34M | 2.96% | 15 |
|
|
2022
Q2 | $30.3M | Sell |
62,871
-27,283
| -30% | -$13.5M | 2.48% | 18 |
|
|
2022
Q1 | $44.3M | Sell |
90,154
-30,448
| -25% | -$13.9M | 3.08% | 12 |
|
|
2021
Q4 | $55.9M | Sell |
120,602
-181,765
| -60% | -$76.5M | 3.42% | 7 |
|
|
2021
Q3 | $113M | Sell |
302,367
-151,786
| -33% | -$57.7M | 3.44% | 5 |
|
|
2021
Q2 | $173M | Sell |
454,153
-20,920
| -4% | -$7.99M | 3.03% | 8 |
|
|
2021
Q1 | $171M | Sell |
475,073
-34,686
| -7% | -$11.2M | 2.91% | 7 |
|
|
2020
Q4 | $164M | Sell |
509,759
-62,628
| -11% | -$19.2M | 2.98% | 11 |
|
|
2020
Q3 | $154M | Sell |
572,387
-20,864
| -4% | -$5.61M | 3.36% | 9 |
|
|
2020
Q2 | $156M | Sell |
593,251
-94,338
| -14% | -$25.2M | 3.44% | 9 |
|
|
2020
Q1 | $156M | Sell |
687,589
-36,841
| -5% | -$10M | 3.78% | 8 |
|
|
2019
Q4 | $219M | Sell |
724,430
-123,516
| -15% | -$34M | 3.59% | 6 |
|
|
2019
Q3 | $204M | Sell |
847,946
-144,783
| -15% | -$39.7M | 3.19% | 9 |
|
|
2019
Q2 | $280M | Sell |
992,729
-211,588
| -18% | -$57.8M | 4.05% | 3 |
|
|
2019
Q1 | $346M | Sell |
1,204,317
-224,020
| -16% | -$64.8M | 4.4% | 1 |
|
|
2018
Q4 | $375M | Sell |
1,428,337
-140,832
| -9% | -$38.7M | 5.03% | 1 |
|
|
2018
Q3 | $430M | Buy |
1,569,169
+884,335
| +129% | +$230M | 4.31% | 1 |
|
|
2018
Q2 | $163M | Buy |
+684,834
| New | +$159M | 1.51% | 35 |
|
Other funds holding ELV
VCM
VPM
Iridian Asset Management's ELV Position: Q1 2026 in Review
Iridian Asset Management reduced its Elevance Health (ELV) stake by 14% in Q1 2026, selling an estimated $1.13M and leaving 21,625 shares worth $6.33M. The position accounts for 2.57% of the portfolio, ranked #12.
Iridian Asset Management first reported a position in ELV in Q2 2018 and has held it in 32 quarters since. The position peaked at $430M in Q3 2018. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Iridian Asset Management held 21,625 shares of Elevance Health worth $6.33M as of Q1 2026.
- Iridian Asset Management sold 3,449 Elevance Health shares in Q1 2026, an estimated $1.13M.
- Elevance Health made up 2.57% of Iridian Asset Management's portfolio in Q1 2026, its #12 holding.
- Iridian Asset Management first reported a position in Elevance Health in Q2 2018 and has held it in 32 quarters since.
- Iridian Asset Management's Elevance Health position peaked at $430M in Q3 2018.
- 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Iridian Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.